Not Signed In - New Study Shows Actonel Almost Halves The Risk Of Hip Fractures Compared To Alendronate
Fri, 24 Nov 2006 11:00 AM EST
... Data published from a retrospective study of over 33,000 postmenopausal women showed that among patients newly prescribed one of the two most popular osteoporosis treatments, patients taking Actonel® (risedronate sodium) were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. [click link for full article] ...
Related Topics
- Risedronate
- Alendronate
- Fractures
- Hip Injuries & Fractures
- Hip Replacement
- Rose Hips
- Risk Factors
- Dysplasia
- Security Risk Assessment
- Bursitis
- Cardiac Risk
- High Risk Pregnancy
- Youth Risk Behaviors
- Cardiovascular Diseases And Disorders
- Dislocations
- Spinal Fractures
- Compression Fractures
- Stress fractures
- Spontaneous fractures
- Fractures due to osteoporosis
email this page
print this page
bookmark this page
feedback on this page
